Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

FDA Stops Imports of Ranbaxy Products
The U.S. Food and Drug Administration (FDA) is stopping the import of several drug products produced by the generic drug manufacturer Ranbaxy Laboratories, Ltd.  The FDA is concerned that Ranbaxy facilities in India are not following U.S. standards for good manufacturing practices.  Although fosinopril is one of the medications manufactured by Ranbaxy, drug shortages are not expected because, in most instances, there are enough other suppliers that can help meet demand for fosinopril. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116949.htm
Learn More

FDA Stops Imports of Ranbaxy Products
The U.S. Food and Drug Administration (FDA) is stopping the import of several drug products produced by the generic drug manufacturer Ranbaxy Laboratories, Ltd.  The FDA is concerned that Ranbaxy facilities in India are not following U.S. standards for good manufacturing practices.  Although gabapentin is one of the medications manufactured by Ranbaxy, drug shortages are not expected because, in most instances, there are enough other suppliers that can help meet demand for gabapentin. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116949.htm
Learn More